ASIF420 Global Cannabis Ventures
Investors

Ventures Portfolio

Tomorrow Genetics

Nurturing Exceptional Cannabis Strains

The strains we acquire in our portfolio have the highest market demand in countries like: Germany. The products can be sold through pharmaceuticals dispensaries across Europe under medical prescriptions.

we-grow-linked-post-incoming

Best selling cannabis strains

We offer the most attractive medical grade cannabis genetics, used by the European medical care system for cannabinoid treatments in the most competitive price ranges for distribution partners.

genetics-eu-gmp2

EU-GMP Cultivation Guidance

Our skilled cannabis cultivators have years of experience operating in a highly regulated markets and growing medical grade products in a greenhouse hydroponic environment.

Venture Details

  • Vertical: Research
  • Portfolio: 12 High Quality Medical Strains
  • Target Markets: Medical Cultivators & Producers
  • Stage: Fully operational since Q2 2021
  • Employees: <5
we-grow-catalog

High quality Medical Genetics

Tomorrow Genetic's Medical Grade Seed Catalog is made of the finest cannabis genetics which are recognized for their quality and purity.

Request your copy - TODAY!

Enter your mail to get the catalog

From the newsroom

ASIF420 Announces Initiation of Cultivation and Breeding of Cannabis Varieties with Unique Genetic Profiles for the Development of Medical Cannabis Products
ASIF420 Forecast: Cannabis Business Opportunities in Emerging Markets
ASIF420 Announces Final Construction Phase of Medical Cannabis Cultivation Center in Lesotho

See more updates from ASIF420 Ventures in the Newsroom center

Get in touch

  • Tel-Aviv, Israel
    Lesotho, South Africa
    Berlin, Germany
  • +972-52-3386662
  • info@asif420.com
    pr@asif420.com

Useful Recourses

Subscribe for updates

Follow us on social

Linkedin Twitter Youtube

ASIF 420 - International CannaTech Ventures Group

All Rights Reserved - 2022